dc.contributor |
Eberhard Karls Universität Tübingen |
de_DE |
dc.contributor.author |
Todenhöfer, Tilman Wolfgang |
de_DE |
dc.date.accessioned |
2016-11-30T10:26:29Z |
|
dc.date.available |
2016-11-30T10:26:29Z |
|
dc.date.issued |
2016 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/73276 |
|
dc.language.iso |
en |
|
dc.publisher |
Tübingen |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Targeting lactate transport for the treatment of urothelial carcinoma - a study on the role of MCT1, MCT4 and CD 147 in muscle-invasive bladder cancer |
de_DE |
dc.type |
Habilitation |
de_DE |
utue.artikel.swb |
480147868 |
de_DE |
utue.kommentar.intern |
Habilitationsschrift, Eberhard-Karls-Universität Tübingen, 2016 |
de_DE |
utue.personen.pnd |
Todenhöfer, Tilman Wolfgang/314152288 |
de_DE |
utue.personen.roh |
Todenhöfer, Tilman Wolfgang |
de_DE |
utue.publikation.seitengesamt |
VI, 152 Blätter : Illustrationen |
de_DE |
utue.titel.verfasserangabe |
vorgelegt von Dr. med. Tilman Wolfgang Todenhöfer |
de_DE |
utue.publikation.swbdatum |
1611 |
de_DE |
utue.publikation.ddcroh |
610 |
de_DE |